Neutral
NovoCure Unifies Clinical And Innovation Roles As Market Discounts Persist
NovoCure (NasdaqGS:NVCR) has combined its Chief Medical Officer and Chief Innovation Officer roles, appointing Uri Weinberg to both positions. This mo...